Obstructive Sleep Apnoea and Difficult Asthma (OSADA)
NCT: NCT07160868 · RECRUITING
Brief Summary
The OSADA (Obstructive Sleep Apnoea in Difficult Asthma) trial is an open-label, randomized control trial investigating the impact of diagnosing and treating obstructive sleep apnoea (OSA) on a asthma control in patients with difficult-to-control asthma. Participants will undergo home-based sleep studies to assess for OSA and are then allocated to one of three arms: 1) Patients with OSA treated with CPAP (intervention group), 2) Patients with OSA not treated for OSA (control group) and 3) Patients without OSA (reference group). The primary objective is to evaluate whether treating OSA improves asthma control, symptom burden, and quality of life compared to untreated OSA and to patients without OSA. Secondary outcomes include exacerbation rates, sleep quality, and healthcare utilization. This trial aims to clarify the contribution of OSA to poor asthma control and the potential benefits of integrated sleep and respiratory care in this complex population.
Frequently Asked Questions
What is Obstructive Sleep Apnoea and Difficult Asthma (OSADA)?
Obstructive Sleep Apnoea and Difficult Asthma (OSADA) is a clinical trial registered under NCT07160868. Current status: RECRUITING.
What is the status of NCT07160868?
The current status of NCT07160868 (Obstructive Sleep Apnoea and Difficult Asthma (OSADA)) is: RECRUITING.
When did Obstructive Sleep Apnoea and Difficult Asthma (OSADA) start?
Obstructive Sleep Apnoea and Difficult Asthma (OSADA) started on 2025-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.